Geriatric Medicines Market - Global Outlook and Forecast 2021-2027

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Geriatric Medicines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Geriatric Medicines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Geriatric Medicines Overall Market Size
2.1 Global Geriatric Medicines Market Size: 2021 VS 2027
2.2 Global Geriatric Medicines Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Geriatric Medicines Players in Global Market
3.2 Top Global Geriatric Medicines Companies Ranked by Revenue
3.3 Global Geriatric Medicines Revenue by Companies
3.4 Top 3 and Top 5 Geriatric Medicines Companies in Global Market, by Revenue in 2020
3.5 Global Companies Geriatric Medicines Product Type
3.6 Tier 1, Tier 2 and Tier 3 Geriatric Medicines Players in Global Market
3.6.1 List of Global Tier 1 Geriatric Medicines Companies
3.6.2 List of Global Tier 2 and Tier 3 Geriatric Medicines Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Geriatric Medicines Market Size Markets, 2021 & 2027
4.1.2 Analgesics
4.1.3 Antihypertensives
4.1.4 Statins
4.1.5 Antidiabetics
4.1.6 Proton Pump Inhibitor
4.1.7 Anticoagulant
4.1.8 Antipsychotics
4.1.9 Antidepressants
4.2 By Type - Global Geriatric Medicines Revenue & Forecasts
4.2.1 By Type - Global Geriatric Medicines Revenue, 2016-2021
4.2.2 By Type - Global Geriatric Medicines Revenue, 2022-2027
4.2.3 By Type - Global Geriatric Medicines Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Geriatric Medicines Market Size, 2021 & 2027
5.1.2 Cardiovascular diseases
5.1.3 Arthritis
5.1.4 Neurological Disorders
5.1.5 Cancer
5.1.6 Osteoporosis
5.1.7 Respiratory
5.2 By Application - Global Geriatric Medicines Revenue & Forecasts
5.2.1 By Application - Global Geriatric Medicines Revenue, 2016-2021
5.2.2 By Application - Global Geriatric Medicines Revenue, 2022-2027
5.2.3 By Application - Global Geriatric Medicines Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Geriatric Medicines Market Size, 2021 & 2027
6.2 By Region - Global Geriatric Medicines Revenue & Forecasts
6.2.1 By Region - Global Geriatric Medicines Revenue, 2016-2021
6.2.2 By Region - Global Geriatric Medicines Revenue, 2022-2027
6.2.3 By Region - Global Geriatric Medicines Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Geriatric Medicines Revenue, 2016-2027
6.3.2 US Geriatric Medicines Market Size, 2016-2027
6.3.3 Canada Geriatric Medicines Market Size, 2016-2027
6.3.4 Mexico Geriatric Medicines Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Geriatric Medicines Revenue, 2016-2027
6.4.2 Germany Geriatric Medicines Market Size, 2016-2027
6.4.3 France Geriatric Medicines Market Size, 2016-2027
6.4.4 U.K. Geriatric Medicines Market Size, 2016-2027
6.4.5 Italy Geriatric Medicines Market Size, 2016-2027
6.4.6 Russia Geriatric Medicines Market Size, 2016-2027
6.4.7 Nordic Countries Geriatric Medicines Market Size, 2016-2027
6.4.8 Benelux Geriatric Medicines Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Geriatric Medicines Revenue, 2016-2027
6.5.2 China Geriatric Medicines Market Size, 2016-2027
6.5.3 Japan Geriatric Medicines Market Size, 2016-2027
6.5.4 South Korea Geriatric Medicines Market Size, 2016-2027
6.5.5 Southeast Asia Geriatric Medicines Market Size, 2016-2027
6.5.6 India Geriatric Medicines Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Geriatric Medicines Revenue, 2016-2027
6.6.2 Brazil Geriatric Medicines Market Size, 2016-2027
6.6.3 Argentina Geriatric Medicines Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Geriatric Medicines Revenue, 2016-2027
6.7.2 Turkey Geriatric Medicines Market Size, 2016-2027
6.7.3 Israel Geriatric Medicines Market Size, 2016-2027
6.7.4 Saudi Arabia Geriatric Medicines Market Size, 2016-2027
6.7.5 UAE Geriatric Medicines Market Size, 2016-2027
7 Players Profiles
7.1 Eli Lilly and Company
7.1.1 Eli Lilly and Company Corporate Summary
7.1.2 Eli Lilly and Company Business Overview
7.1.3 Eli Lilly and Company Geriatric Medicines Major Product Offerings
7.1.4 Eli Lilly and Company Geriatric Medicines Revenue in Global (2016-2021)
7.1.5 Eli Lilly and Company Key News
7.2 AstraZeneca
7.2.1 AstraZeneca Corporate Summary
7.2.2 AstraZeneca Business Overview
7.2.3 AstraZeneca Geriatric Medicines Major Product Offerings
7.2.4 AstraZeneca Geriatric Medicines Revenue in Global (2016-2021)
7.2.5 AstraZeneca Key News
7.3 Boehringer Ingelheim
7.3.1 Boehringer Ingelheim Corporate Summary
7.3.2 Boehringer Ingelheim Business Overview
7.3.3 Boehringer Ingelheim Geriatric Medicines Major Product Offerings
7.3.4 Boehringer Ingelheim Geriatric Medicines Revenue in Global (2016-2021)
7.3.5 Boehringer Ingelheim Key News
7.4 Abbott Laboratories
7.4.1 Abbott Laboratories Corporate Summary
7.4.2 Abbott Laboratories Business Overview
7.4.3 Abbott Laboratories Geriatric Medicines Major Product Offerings
7.4.4 Abbott Laboratories Geriatric Medicines Revenue in Global (2016-2021)
7.4.5 Abbott Laboratories Key News
7.5 Sanofi
7.5.1 Sanofi Corporate Summary
7.5.2 Sanofi Business Overview
7.5.3 Sanofi Geriatric Medicines Major Product Offerings
7.5.4 Sanofi Geriatric Medicines Revenue in Global (2016-2021)
7.5.5 Sanofi Key News
7.6 Bristol-Myers Squibb
7.6.1 Bristol-Myers Squibb Corporate Summary
7.6.2 Bristol-Myers Squibb Business Overview
7.6.3 Bristol-Myers Squibb Geriatric Medicines Major Product Offerings
7.6.4 Bristol-Myers Squibb Geriatric Medicines Revenue in Global (2016-2021)
7.6.5 Bristol-Myers Squibb Key News
7.7 Merck
7.7.1 Merck Corporate Summary
7.7.2 Merck Business Overview
7.7.3 Merck Geriatric Medicines Major Product Offerings
7.4.4 Merck Geriatric Medicines Revenue in Global (2016-2021)
7.7.5 Merck Key News
7.8 Novartis
7.8.1 Novartis Corporate Summary
7.8.2 Novartis Business Overview
7.8.3 Novartis Geriatric Medicines Major Product Offerings
7.8.4 Novartis Geriatric Medicines Revenue in Global (2016-2021)
7.8.5 Novartis Key News
7.9 Pfizer
7.9.1 Pfizer Corporate Summary
7.9.2 Pfizer Business Overview
7.9.3 Pfizer Geriatric Medicines Major Product Offerings
7.9.4 Pfizer Geriatric Medicines Revenue in Global (2016-2021)
7.9.5 Pfizer Key News
7.10 GSK
7.10.1 GSK Corporate Summary
7.10.2 GSK Business Overview
7.10.3 GSK Geriatric Medicines Major Product Offerings
7.10.4 GSK Geriatric Medicines Revenue in Global (2016-2021)
7.10.5 GSK Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer


List of Tables
Table 1. Geriatric Medicines Market Opportunities & Trends in Global Market
Table 2. Geriatric Medicines Market Drivers in Global Market
Table 3. Geriatric Medicines Market Restraints in Global Market
Table 4. Key Players of Geriatric Medicines in Global Market
Table 5. Top Geriatric Medicines Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Geriatric Medicines Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Geriatric Medicines Revenue Share by Companies, 2016-2021
Table 8. Global Companies Geriatric Medicines Product Type
Table 9. List of Global Tier 1 Geriatric Medicines Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Geriatric Medicines Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Geriatric Medicines Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Geriatric Medicines Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Geriatric Medicines Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application - Global Geriatric Medicines Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Geriatric Medicines Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Geriatric Medicines Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region - Global Geriatric Medicines Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Geriatric Medicines Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Geriatric Medicines Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Geriatric Medicines Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Geriatric Medicines Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Geriatric Medicines Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Geriatric Medicines Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Geriatric Medicines Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Geriatric Medicines Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Geriatric Medicines Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Geriatric Medicines Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Geriatric Medicines Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Geriatric Medicines Revenue, (US$, Mn), 2022-2027
Table 30. Eli Lilly and Company Corporate Summary
Table 31. Eli Lilly and Company Geriatric Medicines Product Offerings
Table 32. Eli Lilly and Company Geriatric Medicines Revenue (US$, Mn), (2016-2021)
Table 33. AstraZeneca Corporate Summary
Table 34. AstraZeneca Geriatric Medicines Product Offerings
Table 35. AstraZeneca Geriatric Medicines Revenue (US$, Mn), (2016-2021)
Table 36. Boehringer Ingelheim Corporate Summary
Table 37. Boehringer Ingelheim Geriatric Medicines Product Offerings
Table 38. Boehringer Ingelheim Geriatric Medicines Revenue (US$, Mn), (2016-2021)
Table 39. Abbott Laboratories Corporate Summary
Table 40. Abbott Laboratories Geriatric Medicines Product Offerings
Table 41. Abbott Laboratories Geriatric Medicines Revenue (US$, Mn), (2016-2021)
Table 42. Sanofi Corporate Summary
Table 43. Sanofi Geriatric Medicines Product Offerings
Table 44. Sanofi Geriatric Medicines Revenue (US$, Mn), (2016-2021)
Table 45. Bristol-Myers Squibb Corporate Summary
Table 46. Bristol-Myers Squibb Geriatric Medicines Product Offerings
Table 47. Bristol-Myers Squibb Geriatric Medicines Revenue (US$, Mn), (2016-2021)
Table 48. Merck Corporate Summary
Table 49. Merck Geriatric Medicines Product Offerings
Table 50. Merck Geriatric Medicines Revenue (US$, Mn), (2016-2021)
Table 51. Novartis Corporate Summary
Table 52. Novartis Geriatric Medicines Product Offerings
Table 53. Novartis Geriatric Medicines Revenue (US$, Mn), (2016-2021)
Table 54. Pfizer Corporate Summary
Table 55. Pfizer Geriatric Medicines Product Offerings
Table 56. Pfizer Geriatric Medicines Revenue (US$, Mn), (2016-2021)
Table 57. GSK Corporate Summary
Table 58. GSK Geriatric Medicines Product Offerings
Table 59. GSK Geriatric Medicines Revenue (US$, Mn), (2016-2021)
List of Figures
Figure 1. Geriatric Medicines Segment by Type
Figure 2. Geriatric Medicines Segment by Application
Figure 3. Global Geriatric Medicines Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Geriatric Medicines Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Geriatric Medicines Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Geriatric Medicines Revenue in 2020
Figure 8. By Type - Global Geriatric Medicines Revenue Market Share, 2016-2027
Figure 9. By Application - Global Geriatric Medicines Revenue Market Share, 2016-2027
Figure 10. By Region - Global Geriatric Medicines Revenue Market Share, 2016-2027
Figure 11. By Country - North America Geriatric Medicines Revenue Market Share, 2016-2027
Figure 12. US Geriatric Medicines Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Geriatric Medicines Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Geriatric Medicines Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Geriatric Medicines Revenue Market Share, 2016-2027
Figure 16. Germany Geriatric Medicines Revenue, (US$, Mn), 2016-2027
Figure 17. France Geriatric Medicines Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Geriatric Medicines Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Geriatric Medicines Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Geriatric Medicines Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Geriatric Medicines Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Geriatric Medicines Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Geriatric Medicines Revenue Market Share, 2016-2027
Figure 24. China Geriatric Medicines Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Geriatric Medicines Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Geriatric Medicines Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Geriatric Medicines Revenue, (US$, Mn), 2016-2027
Figure 28. India Geriatric Medicines Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Geriatric Medicines Revenue Market Share, 2016-2027
Figure 30. Brazil Geriatric Medicines Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Geriatric Medicines Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Geriatric Medicines Revenue Market Share, 2016-2027
Figure 33. Turkey Geriatric Medicines Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Geriatric Medicines Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Geriatric Medicines Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Geriatric Medicines Revenue, (US$, Mn), 2016-2027
Figure 37. Eli Lilly and Company Geriatric Medicines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. AstraZeneca Geriatric Medicines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Boehringer Ingelheim Geriatric Medicines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Abbott Laboratories Geriatric Medicines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Sanofi Geriatric Medicines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Bristol-Myers Squibb Geriatric Medicines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Merck Geriatric Medicines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Novartis Geriatric Medicines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Pfizer Geriatric Medicines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. GSK Geriatric Medicines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Eli Lilly and Company
AstraZeneca
Boehringer Ingelheim
Abbott Laboratories
Sanofi
Bristol-Myers Squibb
Merck
Novartis
Pfizer
GSK